TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 120 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2020. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $186,938,000 | +88.2% | 2,484,220 | -32.9% | 14.14% | +85.3% |
Q1 2022 | $99,345,000 | -31.2% | 3,700,000 | +22.3% | 7.63% | -11.1% |
Q4 2021 | $144,292,000 | -23.6% | 3,025,000 | +6.4% | 8.58% | +11.9% |
Q3 2021 | $188,814,000 | -20.3% | 2,842,297 | -6.4% | 7.67% | -4.7% |
Q2 2021 | $236,950,000 | -8.9% | 3,037,042 | +10.4% | 8.05% | +38.9% |
Q1 2021 | $260,122,000 | -10.8% | 2,750,000 | +15.0% | 5.80% | -16.5% |
Q4 2020 | $291,501,000 | +36.6% | 2,392,297 | -2.0% | 6.94% | -15.4% |
Q3 2020 | $213,359,000 | +20.7% | 2,442,297 | -10.8% | 8.20% | +21.6% |
Q2 2020 | $176,802,000 | +29.5% | 2,737,297 | -10.5% | 6.75% | +6.4% |
Q1 2020 | $136,517,000 | -35.5% | 3,056,797 | -10.0% | 6.34% | -24.9% |
Q4 2019 | $211,577,000 | +58.9% | 3,396,650 | -4.1% | 8.44% | +4.2% |
Q3 2019 | $133,155,000 | +4.8% | 3,541,367 | +13.4% | 8.10% | +11.0% |
Q2 2019 | $127,080,000 | – | 3,122,367 | – | 7.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |